title: Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients.
authors.affiliation: University of Bari.
authors.forename: G
authors.initials: G
authors.lastname: Carrieri
authors.forename: M L
authors.initials: ML
authors.lastname: Jordan
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: V P
authors.initials: VP
authors.lastname: Scantlebury
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: S
authors.initials: S
authors.lastname: Kusne
authors.forename: M
authors.initials: M
authors.lastname: Magnone
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D012086:Reoperation; D012307:Risk Factors; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D000212:Acyclovir